MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TOVX has $38,239K in assets. $22,856K in debts. $13,056K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
174.43%
Quick Ratio
174.43%
Cash Ratio
130.38%
Debt to Asset Ratio
59.77%
Unit: Thousand (K) dollars
Assets Breakdown
    • In-process research and developm...
    • Cash and cash equivalents
    • Tax credit receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-current contingent considera...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
13,056
Tax credit receivable
3,351
Prepaid expenses and other current assets
1,060
Total current assets
17,467
Property and equipment, net
222
Restricted cash
46
Right of use asset
803
In-process research and development
19,619
Deposits and other assets
82
Total assets
38,239
Accounts payable
1,014
Accrued expenses
6,276
Accrued employee benefits
443
Deferred research and development tax credit-current portion
1,675
Loans payable-current
57
Operating lease liability-current portion
549
Total current liabilities
10,014
Non-current contingent consideration
10,004
Loan payable - non-current
1,671
Non-current deferred research and development tax credit
815
Non-current operating lease liability
352
Total liabilities
22,856
Common stock, 0.001 par value 350,000,000 shares authorized, 35,717,159 issued and 35,688,350 outstanding at december 31, 2025 and 2,811,259 issued and 2,782,449 outstanding at december 31, 2024
34
Additional paid-in capital
373,592
Treasury stock at cost, 28,809 shares at december 31, 2025 and at december 31, 2024
288
Accumulated other comprehensive income (loss)
755
Accumulated deficit
-358,710
Total stockholders' equity
15,383
Total liabilities and stockholders' equity
38,239
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$13,056K Tax creditreceivable$3,351K Prepaid expenses andother current assets$1,060K In-process research anddevelopment$19,619K Total current assets$17,467K Right of use asset$803K Property and equipment,net$222K Deposits and other assets$82K Restricted cash$46K Total assets$38,239K Total liabilities andstockholders' equity$38,239K Total liabilities$22,856K Total stockholders'equity$15,383K Accumulated deficit-$358,710K Treasury stock at cost,28,809 shares at...$288K Total currentliabilities$10,014K Non-current contingentconsideration$10,004K Loan payable -non-current$1,671K Non-current deferredresearch and development...$815K Non-current operating leaseliability$352K Additional paid-in capital$373,592K Accumulated othercomprehensive income (loss)$755K Common stock, 0.001 parvalue 350,000,000...$34K Accrued expenses$6,276K Deferred research anddevelopment tax...$1,675K Accounts payable$1,014K Operating leaseliability-current portion$549K Accrued employeebenefits$443K Loanspayable-current$57K

Theriva Biologics, Inc. (TOVX)

Theriva Biologics, Inc. (TOVX)